Literature DB >> 28739757

Multifocal and Multicentric Breast Carcinoma: A Significantly More Aggressive Tumor than Unifocal Breast Cancer.

Zhiqiang Lang1, Yanqiu Wu2, Cuiyan Li2, Xinna Li1, Xuan Wang3, Guimei Qu4.   

Abstract

BACKGROUND/AIM: There are still many questions that surround multifocal or multicentric breast carcinoma (MMBC). The aim of this study was to analyze the clinicopathological characteristics of MMBC and provide feasible suggestions for therapy. PATIENTS AND METHODS: A total of 156 cases of MMBC in 3,597 invasive ductal breast carcinomas were collected and reviewed. Some factors related with prognosis such as tumor size, lymph node metastasis and others were assessed in each tumor focus, and mismatches among foci were recorded.
RESULTS: The majority of MMBC had aggregate dimensions over 2 cm (85.90%). The rate of axillary lymph node metastasis was 56.41% (88/156) compared to unifocal tumors of 33.01% (1,136/3,441). Most cases had higher Ki-67 proliferative indices (91/156). Mismatches in ER status were present in 6 cases, PR in 4 cases, proliferative index (Ki-67) in 9 cases and HER2-positive status in 2 cases.
CONCLUSION: The larger aggregate dimension of tumor, the higher metastatic rate of axillary lymph node and the high Ki-67 proliferative index seen in most cases, suggest that MMBC is biologically more aggressive than unifocal breast cancer. In addition, every focus should be tested owing to the existence of different expressions of immunostaining between foci. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ER; HER2; Multifocal and multicentric breast carcinoma; PR

Mesh:

Substances:

Year:  2017        PMID: 28739757     DOI: 10.21873/anticanres.11858

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients.

Authors:  Lei Feng; Lei Sheng; Litao Zhang; Na Li; Yuanzhong Xie
Journal:  Contrast Media Mol Imaging       Date:  2022-04-06       Impact factor: 3.009

Review 2.  The sick lobe hypothesis, field cancerisation and the new era of precision breast surgery.

Authors:  Mona P Tan; Tibor Tot
Journal:  Gland Surg       Date:  2018-12

3.  EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases.

Authors:  Alaleh Zati Zehni; Udo Jeschke; Anna Hester; Thomas Kolben; Nina Ditsch; Sven-Niclas Jacob; Jan-Niclas Mumm; Helene Hildegard Heidegger; Sven Mahner; Theresa Vilsmaier
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

4.  Synchronous Multiple Breast Cancers-Do We Need to Reshape Staging?

Authors:  Minodora Onisâi; Adrian Dumitru; Iuliana Iordan; Cătălin Aliuș; Oana Teodor; Adrian Alexandru; Daniela Gheorghiță; Iulian Antoniac; Adriana Nica; Alexandra-Ana Mihăilescu; Sebastian Grădinaru
Journal:  Medicina (Kaunas)       Date:  2020-05-11       Impact factor: 2.430

5.  Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.

Authors:  Alaleh Zati Zehni; Sven-Niclas Jacob; Jan-Niclas Mumm; Helene Hildegard Heidegger; Nina Ditsch; Sven Mahner; Udo Jeschke; Theresa Vilsmaier
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

6.  The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.

Authors:  Alaleh Zati Zehni; Falk Batz; Aurelia Vattai; Till Kaltofen; Svenja Schrader; Sven-Niclas Jacob; Jan-Niclas Mumm; Helene Hildegard Heidegger; Nina Ditsch; Sven Mahner; Udo Jeschke; Theresa Vilsmaier
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

7.  Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC).

Authors:  Taehee Lee; Piper A Rawding; Jiyoon Bu; Sunghee Hyun; Woosun Rou; Hongjae Jeon; Seokhyun Kim; Byungseok Lee; Luke J Kubiatowicz; Dawon Kim; Seungpyo Hong; Hyuksoo Eun
Journal:  Cancers (Basel)       Date:  2022-04-20       Impact factor: 6.639

8.  [Early Recurrence of Breast Cancer after the Primary Treatment: Analysis of Clinicopathological and Radiological Predictive Factors].

Authors:  Sun Geun Yun; Yeong Yi An; Sung Hun Kim; Bong Joo Kang
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-02-18

9.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.